Four insights:
1. Ossiofiber is designed for rapid bone ingrowth, regeneration and replacement.
2. The bio-integrative implant provides the strength required for bone fixation, allowing for integration into the anatomy without adverse biological response.
3. Fusing mechanical strength and natural tissue healing, the implant can be applied to several orthopedic fixations, with a goal to enter extremities, trauma, sports, reconstruction, pediatrics and spine segments next.
4. The Ossiofiber Bone Pin Family received FDA 510(k) clearance in January and launched its first product line in May for use in the foot and ankle segment for the treatment of forefoot conditions where hardware removal surgeries are widespread.
More articles on biologics:
Konica Minolta Healthcare partners with EmCyte in biologics workshop
Bioventus collaborates with MTF Biologics in tissue product for knee osteoarthritis
Dr. Selby Chen of the Mayo Clinic: The major challenges facing spine today
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
